Morgan Stanley Private Equity has acquired ClearMedi Healthcare, one of India’s leading healthcare providers, for an undisclosed amount. This corporate acquisition marks a significant move by the private equity firm to expand its portfolio in the growing Indian healthcare sector.
ClearMedi Healthcare is recognized for its integrated model encompassing specialty hospitals, clinical services, and digital health initiatives. The company focuses on oncology, cardiology, orthopedics, nephrology, and multi-specialty tertiary care, partnering with numerous trusted hospitals and healthcare institutions across India. It emphasizes advanced medical technology, highly experienced clinicians, and a patient-first ethos, aiming to make quality healthcare accessible, affordable, and outcome-driven. ClearMedi also invests in digital innovation and preventive health, including initiatives like "30 Seconds of Health" to promote public awareness and healthier lifestyles.
The acquisition is strategically aligned with Morgan Stanley Private Equity's interest in robust, high-growth sectors. ClearMedi’s established market presence, specialized clinical excellence, and hospital management expertise present a strong platform for investment. Through this acquisition, Morgan Stanley PE is positioned to support ClearMedi's expansion plans, potentially enhancing its network of specialty hospitals and clinical services, and scaling its digital health initiatives. The combination is expected to capitalize on the increasing demand for quality healthcare services in India, leveraging ClearMedi's integrated care model and commitment to patient outcomes.
The combined entity is poised to strengthen its footprint in the Indian healthcare landscape, driven by ClearMedi's operational capabilities and Morgan Stanley PE's strategic and capital support. This acquisition aims to further reinforce ClearMedi's vision of transforming lives through accessible and outcome-driven healthcare solutions across the nation.